University of Maryland, School of Medicine, Baltimore, Maryland, United States of America.
PLoS One. 2013 Jun 12;8(6):e65969. doi: 10.1371/journal.pone.0065969. Print 2013.
Determining the role of vascular receptors in vivo is difficult and not readily accomplished by systemic application of antagonists or genetic manipulations. Here we used intravital microscopy to measure the contributions of sympathetic receptors, particularly α1-adrenoceptor subtypes, to contractile activation of femoral artery in vivo.
Diameter and intracellular calcium ([Ca(2+)]i) in femoral arteries were determined by intravital fluorescence microscopy in mice expressing a Myosin Light Chain Kinase (MLCK) based calcium-calmodulin biosensor. Pharmacological agents were applied locally to the femoral artery to determine the contributions of vascular receptors to tonic contraction and [Ca(2+)]i,.
In the anesthetized animal, femoral arteries were constricted to a diameter equal to 54% of their passive diameter (i.e. tone = 46%). Of this total basal tone, 16% was blocked by RS79948 (0.1 µM) and thus attributable to α2-adrenoceptors. A further 46% was blocked by prazosin (0.1 µM) and thus attributable to α1-adrenoceptors. Blockade of P2X and NPY1 receptors with suramin (0.5 mM) and BIBP3226 (1.0 µM) respectively, reduced tone by a further 22%, leaving 16% of basal tone unaffected at these concentrations of antagonists. Application of RS100329 (α1A-selective antagonist) and BMY7378 (α1D-selective) decreased tone by 29% and 26%, respectively, and reduced [Ca(2+)]i. Chloroethylclonidine (1 µM preferential for α1B-) had no effect. Abolition of sympathetic nerve activity (hexamethonium, i.p.) reduced basal tone by 90%.
Tone of mouse femoral arteries in vivo is almost entirely sympathetic in origin. Activation of α1A- and α1D-adrenoceptors elevates [Ca(2+)]i and accounts for at least 55% of the tone.
在体内确定血管受体的作用是困难的,并且通过全身应用拮抗剂或遗传操作不易完成。在这里,我们使用活体显微镜测量了交感受体(特别是α1-肾上腺素能受体亚型)在体内对股动脉收缩激活的贡献。
在表达肌球蛋白轻链激酶(MLCK)的钙-钙调蛋白生物传感器的小鼠中,通过活体荧光显微镜测量股动脉的直径和细胞内钙([Ca(2+)]i)。局部应用药物来确定血管受体对紧张性收缩和[Ca(2+)]i的贡献。
在麻醉动物中,股动脉收缩至其被动直径的 54%(即张力= 46%)。在总基础张力中,16%被 RS79948(0.1μM)阻断,因此归因于α2-肾上腺素能受体。进一步用哌唑嗪(0.1μM)阻断 46%,因此归因于α1-肾上腺素能受体。用苏拉明(0.5mM)和 BIBP3226(1.0μM)分别阻断 P2X 和 NPY1 受体,使张力进一步降低 22%,在这些拮抗剂浓度下,基础张力的 16%不受影响。应用 RS100329(α1A-选择性拮抗剂)和 BMY7378(α1D-选择性),张力分别降低 29%和 26%,[Ca(2+)]i降低。氯乙基氯胺(1μM 对α1B-有偏好)没有作用。交感神经活动(腹腔注射六烃季铵)的消除使基础张力降低 90%。
体内小鼠股动脉的张力几乎完全来源于交感神经。α1A-和α1D-肾上腺素能受体的激活升高[Ca(2+)]i,并占至少 55%的张力。